Indication
Non-Hodgkin's
2 clinical trials
3 products
Clinical trial
A Phase 1/2 Open-Label Multi-Center Study to Characterize the Safety and Tolerability of CFT7455 in Subjects With Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple MyelomaStatus: Recruiting, Estimated PCD: 2025-09-07
Product
DexamethasoneProduct
CFT7455Clinical trial
PNT2258-02: A Pilot Phase II Study of PNT2258 for Treatment of Relapsed or Refractory Non-Hodgkin's LymphomaStatus: Completed, Estimated PCD: 2016-08-01
Product
PNT2258